par Alonso-Curbelo, Direna;Riveiro-Falkenbach, Erica;Perez-Guijarro, Eva;Cifdaloz, Metehan;Karras, Panagiotis
;Osterloh, Lisa;Megías, Diego;Cañón, Estela;Calvo, Tonantzin T.G.;Olmeda, David;Gómez-López, Gonzalo;Graña, Osvaldo;Sánchez-ArévaloLobo, Víctor Javier;Pisano, David D.G.;Wang, Hao Wei;Ortiz-Romero, Pablo Luis;Tormo, Damià;Hoek, Keith;Rodríguez-Peralto, José Luis;Joyce, Johanna J.A.;Soengas, María M.S.
Référence Cancer cell, 26, 1, page (61-76)
Publication Publié, 2014-07
;Osterloh, Lisa;Megías, Diego;Cañón, Estela;Calvo, Tonantzin T.G.;Olmeda, David;Gómez-López, Gonzalo;Graña, Osvaldo;Sánchez-ArévaloLobo, Víctor Javier;Pisano, David D.G.;Wang, Hao Wei;Ortiz-Romero, Pablo Luis;Tormo, Damià;Hoek, Keith;Rodríguez-Peralto, José Luis;Joyce, Johanna J.A.;Soengas, María M.S.Référence Cancer cell, 26, 1, page (61-76)
Publication Publié, 2014-07
Article révisé par les pairs
| Résumé : | Although common cancer hallmarks are well established, lineage-restricted oncogenes remain less understood. Here, we report an inherent dependency of melanoma cells on the small GTPase RAB7, identified within a lysosomal gene cluster that distinguishes this malignancy from over 35 tumor types. Analyses in human cells, clinical specimens, and mouse models demonstrated that RAB7 is an early-induced melanoma driver whose levels can be tuned to favor tumor invasion, ultimately defining metastatic risk. Importantly, RAB7 levels and function were independent of MITF, the best-characterized melanocyte lineage-specific transcription factor. Instead, we describe the neuroectodermal master modulator SOX10 and the oncogene MYC as RAB7 regulators. These results reveal a unique wiring of the lysosomal pathway that melanomas exploit to foster tumor progression. © 2014 Elsevier Inc. |



